Ratings by Canaccord (Max Masucci)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2021 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
18.06 (4.20) |
-76.74% | Details | |
| 5/11/2021 | Akoya Biosciences Inc | AKYA | New Coverage | Buy (N/A) |
19.13 (1.29) |
-93.26% | Details | |
| 4/28/2021 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2021 | Exagen | XGN | New Coverage | Buy (N/A) |
16.69 (4.67) |
-72.02% | Details | |
| 4/6/2021 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2021 | Illumina | ILMN | Upgrade | Buy (Hold) |
368.96 (160.97) |
-56.37% | Details | |
| 3/15/2021 | GenMark Diagnostics | GNMK | Downgrade | Hold (Buy) |
18.50 (24.04) |
29.95% | Details | |
| 2/16/2021 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2021 | Biodesix | BDSX | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2020 | Biodesix | BDSX | New Coverage | Buy (N/A) |
17.09 (15.06) |
-11.88% | Details | |
| 7/14/2020 | Genetron Holdings Inc. | GTH | New Coverage | Buy (N/A) |
14.05 (4.03) |
-71.32% | Details | |
| 7/8/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2020 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
9.93 (0.46) |
-95.37% | Details | |
| 5/18/2020 | Chembio Diagnostics | CEMI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | Illumina | ILMN | Maintain | Hold (N/A) |
|
Details | ||
| 1/10/2020 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details |
